Navigation Links
Voracious sponges save reef

Tropical oceans are known as the deserts of the sea. And yet this unlikely environment is the very place where the rich and fertile coral reef grows. Dutch researcher Jasper de Goeij investigated how caves in the coral reef ensure the reef's continued existence. Although sponges in these coral caves take up a lot of dissolved organic material, they scarcely grow. However, they do discard a lot of cells that in turn provide food for the organisms on the reef.

Caves in coral reefs are the largest and least well known part of the reef. De Goeij investigated coral caves near Curacao and Indonesia. Up until now it had been assumed that cave sponges could only eat by filtering the non-dissolved particles from the seawater. This research demonstrated, however, that the caves contain far more dissolved material than non-dissolved material.

The reef's guts

Cave sponges take up enormous quantities of dissolved organic material from seawater. The question is whether they merely take up the material or whether they also process it. De Goeij revealed that the sponges process forty percent of the material and take up sixty percent. This should lead to a doubling of the sponges' biomass every two to three days. However, cave sponges scarcely grow.

The coral caves are densely populated and so there is scarcely any space to grow. Instead of growing the cave sponges rapidly rejuvenate their filtration cells and discard their old cells. This short cell cycle is unique for multicellular organisms and to date was only known to occur in unicellular organisms. The production and breakdown process of the sponge cells mirrors that in the human intestinal tract.

Eating and being eaten

Coal reef maintains itself in a remarkable manner. The algae and corals on the reef produce dissolved organic material. Before this material flows into the open ocean sponges in the caves take it up. The sponges rapidly filter enormous quantities of water and convert dissolved material into particles. These particles are in turn consumed by the algae and corals on the reef. In this manner, the various inhabitants of the reef facilitate each other's survival.

Sponges produce many substances that could contribute to the development of new medicines, antibiotics and cosmetics. However, rearing sponges is far from easy. Unravelling how these sponges function could solve this problem and this research has contributed towards this.

Jasper de Goeij's research was funded with a grant from WOTRO Science for Global Development, one of NWO's scientific divisions. De Goeij carried out his work at the Royal Netherlands Institute for Sea Research.


Contact: Jasper de Goeij
Netherlands Organization for Scientific Research

Related biology news :

1. Bacteria from sponges make new pharmaceuticals
Post Your Comments:
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... PUNE, India , November 27, 2015 ... --> Growing popularity of companion ... emerging in cancer biomarkers market with pharmaceutical ... develop in-demand companion diagnostic tests. ... --> Complete report on global ...
(Date:11/26/2015)... , November 26, 2015 --> ... company specializing in imaging technologies, announced today that it has ... part of the Horizon 2020 European Union Framework Programme for ... large-scale clinical trial in breast cancer. , ... --> --> The study ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... Studies reveal the differences in species of bacteria ... for more effective treatment for one of the most commonly ... --> --> Gum disease is one ... relatively little was understood about the bacteria associated with it ... researchers from the WALTHAM Centre for Pet Nutrition together with ...
Breaking Biology Technology: